Kodiak Sciences Announces First Patients Enrolled in Global Phase 3 ALTO trial of KSI-501 in Patients with Diabetic Macular Edema
PR Newswire•10/08/2026•16:43 ET
0
Whiz Insights
Get started
Create a free account to read the full story.
Create a free account to read the full story.